🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07800117
Active, not recruiting Observational

Investigation of the Association of Multimodal Neuroimaging and Peripheral Biomarkers With Executive Functions and Emotional Regulation in Adolescents With Attention-Deficit/Hyperactivity Disorder

NCT07800117 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-03-01
Last updated
2026-09-02

Condition(s) studied

Attention-Deficit/Hyperactivity Disorder (ADHD)

Investigational drug(s) / intervention(s)

No Intervention

No Intervention: This is an observational study. No intervention or treatment is assigned to participants. Participants are assessed using clinical and neuropsychological assessments, resting-state functional magnetic resonance imaging, and peripheral blood biomarker measurements.

Study summary

The purpose of this observational study is to investigate the relationships among resting-state brain connectivity, peripheral blood biomarkers, executive functions, and emotional regulation in adolescents with attention-deficit/hyperactivity disorder (ADHD). The study will include 40 adolescents aged 10 to 18 years with ADHD and 40 age- and sex-matched healthy controls. Participants will undergo clinical and psychological assessments, resting-state functional magnetic resonance imaging, and blood sampling. Serum levels of BDNF, cortisol, IL-1α, IFN-γ, TNF-α, and IL-6 will be measured. The study will examine whether differences in brain connectivity and biomarker levels are associated with executive functioning and emotional regulation.

Eligibility

Sex
ALL
Min age
10 Years
Max age
18 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age 10-18 years, including ages 10 and 18. * Diagnosis of attention-deficit/hyperactivity disorder (ADHD) according to DSM-5 criteria. * Clinically normal intellectual capacity (IQ \>80). * Predominantly right-handed. * No acute or chronic inflammatory disease. Healthy Control Group: * Age 10-18 years, including ages 10 and 18. * No psychiatric diagnosis according to DSM-5 criteria. * Clinically normal intellectual capacity (IQ \>80). * Predominantly right-handed. * No acute or chronic inflammatory disease. Exclusion Criteria: * Age younger than 10 or older than 18 years. * Intellectual disability (IQ \<80). * Hydrocephalus or herniation. * Predominantly left-handed. * History of possible traumatic brain injury. * Current or past neurological or serious medical disease (e.g., epilepsy). * Autism spectrum disorder. * Psychotic disorder. * Mood disorder. * Conduct disorder. * Active anxiety disorder or substance use disorder. * Presence of an acute or chronic inflammatory disease.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Akdeniz University Faculty of Medicine Hospital Antalya Turkey (Türkiye)

More Akdeniz University trials in Turkey

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07800117 on ClinicalTrials.gov ↗ ← All trials in Turkey